Clinical Trial: Study of the Safety and Efficacy of Prenofitol Tablets

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07908433) titled 'Study of the Safety and Efficacy of Prenofitol Tablets' on Oct. 26.

Brief Summary: Stage 1 of the Study

Stage 1 of the study will consist of:

a screening period (Visit 0) conducted within 0-14 days prior to the start of treatment; an inpatient treatment period, including Visit 1 (Days 1-4) and Visit 2 (Days 7-8), during which blood samples will be collected for pharmacokinetic (PK) analysis and safety parameters will be assessed.

Upon completion of the inpatient treatment period, the study data will be submitted to the National Center for Medicines and Medical Devices (NCMD) for analysis and assessment of tolerability and safety p...